mochi health tirzepatide Eli Lilly sues and others for 'deceptive' marketing Mochi Health: GLP-1 & Wellness

Genetic testing has a role for all first-degree relatives when a family history of FH is strongly suggestive, regardless of LDL-C level

Heart protection: in the SELECT trial, semaglutide cut major cardiac events (heart attack, stroke, cardiovascular death) by about 20% in people with obesity and heart disease but no diabetes

What is aspiration and why is it a concern during GLP-1 use

This medication lowers your hunger and gives you more energy

Its ability to reduce hepatic fat and visceral adipose tissue further underscores its potential advantage in treating MASH over GLP-1 RAs [40]

But you should have an appropriate BMI or diabetes (for Ozempic). Horn said more patients are now being prescribed Wegovy for weight loss due to broader interest in Ozempic and other drugs